Infiltrating growing pattern xenografts induced by glioblastoma and anaplastic astrocytoma derived tumor stem cells

Chirurgia (Romania)

Volumn 107, Issue 5, 2010, Pages 685-694

  Brehar, F M ^a   Ciurea, A V ^a   Zarnescu, O ^b   Bleotu, C ^c   Gorgan, R M ^a   Dragu, D ^c   Matei, L ^c  

^a Clinic Hospital Bagdasar Arseni Bucharest   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

Anaplastic astrocytoma; Glioblastoma; Nestin; Tumor stem cells; Xenografts

Indexed keywords

ANIMAL; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER STEM CELL; GLIOBLASTOMA; MOUSE; NUDE MOUSE; PATHOLOGY; PROGNOSIS; XENOGRAFT;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84874078913     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64(19):7011-21. (Pubitemid 39331011)
2. Jones TR, Bigner SH, Schold SC Jr, Eng LF, Bigner DD. Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression. Am J Pathol. 1981; 105(3):316-27. (Pubitemid 12253493)
3. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005;353(8):811-22.
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401. Comment in: Nature. 2004; 432(7015):281-2. (Pubitemid 39551674)
5. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67(9):4010-5. (Pubitemid 46815044)
6. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, Held-Feindt J. Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol. 2008;86(1): 31-45. Epub 2007 Jul 5. (Pubitemid 350263430)
7. Sen P, Nemeth MA, Multani AS. Human tumor xenografts in nude mice are not always of human origin. Cancer. 1998; 83:1891-3. (Pubitemid 28503719)
8. Cattaneo E, McKay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature. 1990;347(6295):762-5.
9. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60(4):585-95.
10. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-8. (Pubitemid 37187480)
11. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004;23(58):9392-400. (Pubitemid 40069671)
12. Zarnescu O, Brehar FM, Chivu M, Ciurea AV. Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts. J Mol Histol. 2008;39(6):561-9. Epub 2008 Sep 24.
13. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R, Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol. 2007;68(2):133-43; discussion 143-4. Epub 2007 May 29. (Pubitemid 47087905)
14. Amberger-Murphy V. Glioma invasion: mechanism, modulation and future possibilities. Acta Neurochir. 2003;145:613-4. (Pubitemid 37094003)
15. Taga T, Gan To Kagaku. Identification of cancer stem cells in the "side population". Ryoho. 2006;33(3):295-9.
16. Vallee RB, Jin-Wu Tsai. The cellular roles of the lissencephaly gene LIS and what they tell us about brain development. Genes Dev. 2006;20:1384-93. (Pubitemid 43830646)
17. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. The role of myosin II in glioma invasion of the brain. Mol Biol Cell. 2008;19(8):3357-68. Epub 2008 May 21.
18. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007;9(4):424-9. Epub 2007 Jul 10.
19. Walton NM, Snyder GE, Park D, Kobeissy F, Scheffler B, Steindler DA. Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation. Stem Cells. 2009;27(2):280-9.
20. Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, et al. Bevazucimab for recurrent malignant gliomas: efficacity, toxicity, and patterns of recurrence. Neurology. 2008; 70:779-787
21. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008;8(8):592-603.
22. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444(7120):761-5. Comment in: Nature. 2006;444(7120): 687-8. (Pubitemid 44949605)
23. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008;68(15):6043-8.
24. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in a9b1 integrin-dependent progression of glioblastoma. Neuro Oncol. 2008;10(6):968-80.